Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Chenyue Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9130-8374; OpenAlex author ID A5101640224. Sources: OpenAlex.

Their work

Papers
10 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 3 papers · 2017: none · 2018: 1 paper · 2019: 3 papers · 2020: none · 2021: 2 papers

Papers 10

  1. A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis. Co-author DOI 10.1158/0008-5472.can-20-0256↗
  2. CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis. First author DOI 10.21037/atm-20-1013↗
  3. Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression. First author DOI 10.1186/s13046-019-1055-9↗
  4. HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients. Co-author DOI 10.2147/ott.s185424↗
  5. High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells. Co-author DOI 10.2147/ott.s185953↗
  6. Prognostic values of common clinical parameters in advanced pancreatic ductal adenocarcinoma: a large multicenter cohort study of ten years. Co-author PMID 29641971↗
  7. Ski modulate the characteristics of pancreatic cancer stem cells via regulating sonic hedgehog signaling pathway. Co-author DOI 10.1007/s13277-016-5461-8↗
  8. Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer. First author DOI 10.18632/oncotarget.12248↗
  9. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter coh… Co-author DOI 10.18632/oncotarget.13000↗
  10. Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer. First author DOI 10.1093/carcin/bgt227↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiqiang Meng · 7 shared papers, 2016–2021 · strength 0.60
  2. Zhouyu Ning · 5 shared papers, 2016–2021 · strength 0.47
  3. Zhen Chen · 5 shared papers, 2016–2021 · strength 0.47
  4. Lianyu Chen · 4 shared papers, 2016–2021 · strength 0.40
  5. Weidong Shi · 4 shared papers, 2016–2021 · strength 0.34
  6. Yongqiang Hua · 3 shared papers, 2016–2021 · strength 0.27
  7. Luming Liu · 3 shared papers, 2016–2019 · strength 0.23
  8. Qiwen Chen · 3 shared papers, 2016–2019 · strength 0.21
  9. Chao Qu · 2 shared papers, 2016–2021 · strength 0.19
  10. Peng Wang · 2 shared papers, 2016–2021 · strength 0.19
  11. Libin Song · 2 shared papers, 2016–2019 · strength 0.17
  12. Luming Liu · 1 shared paper, 2021 · strength 0.13
  13. Zhiqiang Meng · 1 shared paper, 2021 · strength 0.13
  14. Yawen Geng · 1 shared paper, 2021 · strength 0.13
  15. Ling Mei Qian · 1 shared paper, 2021 · strength 0.13
  16. Jie Fan · 1 shared paper, 2021 · strength 0.13
  17. Jing Xie · 1 shared paper, 2019 · strength 0.11
  18. Yehua Shen · 2 shared papers, 2016–2018 · strength 0.11
  19. Lei Wang · 2 shared papers, 2016–2018 · strength 0.11
  20. Shu Dong · 2 shared papers, 2016–2018 · strength 0.11
  21. Yuanbiao Guo · 2 shared papers, 2016–2018 · strength 0.11
  22. Jinming Yu · 2 shared papers, 2016–2018 · strength 0.11
  23. Yan Xia · 1 shared paper, 2019 · strength 0.09
  24. Liping Zhuang · 1 shared paper, 2019 · strength 0.09
  25. Hao Hui Chen · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.